Notice: This company has been marked as potentially delisted and may not be actively trading. Lumos Pharma (LUMO) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Lumos Pharma (NASDAQ:LUMO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$13,899.15 Get LUMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lumos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LUMO Insider Buying and Selling by Quarter Lumos Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/6/2024John C MckewInsiderSell3,407$1.89$6,439.23 4/3/2024John C MckewInsiderSell2,214$2.77$6,132.78 2/6/2024John C MckewInsiderSell438$3.03$1,327.14 (Data available from 1/1/2013 forward) LUMO Insider Trading Activity - Frequently Asked Questions Who is on Lumos Pharma's Insider Roster? The list of insiders at Lumos Pharma includes John C Mckew, Richard J Hawkins, and Thomas A Raffin. Learn more on insiders at LUMO. What percentage of Lumos Pharma stock is owned by insiders? 25.40% of Lumos Pharma stock is owned by insiders. Learn more on LUMO's insider holdings. Which Lumos Pharma insiders have been selling company stock? The following insider sold LUMO shares in the last 24 months: John C Mckew ($32,075.40). How much insider selling is happening at Lumos Pharma? Insiders have sold a total of 11,680 Lumos Pharma shares in the last 24 months for a total of $32,075.40 sold. Lumos Pharma Key ExecutivesMr. Richard J. Hawkins (Age 75)Founder, CEO & Chairman Compensation: $854.35kDr. John C. McKew Ph.D. (Age 60)Chief Scientific Officer & President Compensation: $860.38kMs. Lori D. Lawley CPA (Age 40)CFO & Principal Accounting Officer Compensation: $538.23kMs. Lisa Wells MillerSenior Director of Investor RelationsMr. Bradley J. Powers J.D. (Age 45)Chief Compliance Officer & General Counsel Compensation: $677.08kMr. Aaron Schuchart B.B.A. (Age 58)CPA, M.B.A., Chief Business Officer Dr. Pisit Pitukcheewanont FAAPM.D., Chief Medical OfficerMr. Eddie L. Varnado M.B.A.Corporate Controller More Insider Trading Tools from MarketBeat Related Companies FTLF Insider Ownership ADAP Insider Ownership PBYI Insider Ownership CRBP Insider Ownership FATE Insider Ownership BMEA Insider Ownership KYTX Insider Ownership INMB Insider Ownership VTYX Insider Ownership CRBU Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:LUMO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lumos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUMO Stock Alerts